Today

Agents

Chat

Arena

Discover

More

App

Avalo Therapeutics CMO Mittie Doyle sells 679 common shares for $13,580 - AVTX News | Rallies

Avalo Therapeutics CMO Mittie Doyle sells 679 common shares for $13,580

AVTX•2026-09-01

Insider share sale after option exercise

Avalo Therapeutics Chief Medical Officer Doyle Mittie sold 679 common shares at USD 20 on Aug. 28, 2026.
The sale followed the exercise of 679 stock options at USD 8.04 on the same date.
Mittie held 51,776 common shares after the transactions.

Related News

Guggenheim Investments Announces September 2026 Closed-End Fund Distributions

AVK•2026-09-01

Capital Southwest shareholders approve increase in authorized common shares to 135 million

CSWC•2026-09-01

Barinthus Biotherapeutics faces Nasdaq listing-rule breach as ADS trading halt nears Sept. 9

Sources

S

Avalo Therapeutics CMO Mittie Doyle sells 679 common shares for $13,580

Sec

BRNS•2026-09-01

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ZNTL•2026-09-01

RedCloud files Form 3 initial beneficial ownership statement for CFO David Sturgeon

RCT•2026-09-01